Home › Interstitial Lung Diseases › Michigan › Ann Arbor
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Ann Arbor, MI
Isang pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Ann Arbor. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Nagre-recruitPhase 3
- University of Michigan, Ann Arbor
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Nagre-recruitPhase 3
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
- GSK Investigational Site, Ann Arbor
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Nagre-recruit
- University of Michigan - Michigan Medicine, Ann Arbor
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
- Clinical Research Site, Ann Arbor
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- University of Michigan, Ann Arbor
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Nagre-recruitPhase 2
- University of Michigan, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Nagre-recruitPhase 2
- Galderma Investigational Site # 8743, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod
- New York City, NY18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Kansas City, KS13 pag-aaral
- Durham, NC13 pag-aaral
- Charleston, SC13 pag-aaral
- Chicago, IL12 pag-aaral
- Houston, TX12 pag-aaral
- Aurora, CO11 pag-aaral
- Phoenix, AZ9 pag-aaral
- Salt Lake City, UT9 pag-aaral
- Boston, MA9 pag-aaral
Iba pang pag-aaral sa Ann Arbor
- Kanser sa Prostate27 pag-aaral
- Kanser sa Suso26 pag-aaral
- Non-Small Cell Lung Cancer26 pag-aaral
- Kanser (lahat ng uri)25 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser sa Pancreas14 pag-aaral
- Melanoma12 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)12 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.